SYH-2066

N/A

Report date: 2025/09/12 11:08:26
NME

Base Information

Drug NameSYH-2066
Drug Alias NameSYH2066SYH-2066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCspc Ouyi Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCspc Ouyi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus InfectionsRespiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A